Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

464
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
464
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

243
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
243
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

361
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
361
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

601
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
601
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

280
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
280

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Tibial Slope Morphology and Lateral-Medial Tibial Slope Asymmetry With Revision ACL Reconstruction in an Asian Cohort.

Orthopaedic journal of sports medicine·2026
Same author

Phosphate Starvation Shapes M<sup>6</sup>A Modification and Poly(A) Tails to Regulate mRNA Decay in Rice.

Plant, cell & environment·2026
Same author

Context-dependent miRNA regulation in intervertebral disc degeneration: an IDD-focused dynamic network framework for stage-specific therapeutics.

Frontiers in cell and developmental biology·2026
Same author

Attitudes, and practices toward allergic rhinitis: a comparative cross-sectional study of patients and non-patients in China.

Frontiers in medicine·2026
Same author

Crystallographic Capture of a Free Triplet Borylnitrene.

Journal of the American Chemical Society·2026
Same author

OsMAPK20-1 and OsMAPK20-4 phosphorylate OsCK2β3 to regulate its stability in response to phosphate starvation in rice.

Plant physiology·2026

Related Experiment Video

Updated: Dec 19, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Characterizing the critical features when personalizing antihypertensive drugs using spectrum analysis and machine

Liu Chunyu1, Liu Ran2, Zhou Junteng3

  • 1Pharmacy Department, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China.

Artificial Intelligence in Medicine
|June 6, 2020
PubMed
Summary

This study uses data mining to identify key patient features for five hypertension drugs, improving personalized treatment selection. The findings offer a data-driven approach to more effective hypertension management.

Keywords:
Antihypertensive drugsBlood pressure controlData mining methodsDrug-related attributesMachine learning

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Dec 19, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Cardiology
  • Pharmacology
  • Medical Informatics

Background:

  • Current hypertension treatment faces challenges in prescribing optimal drugs based on individual patient characteristics.
  • Identifying specific clinical features associated with drug effectiveness is crucial for efficient hypertension management.

Purpose of the Study:

  • To apply data mining techniques to determine the clinical characteristic spectrum for five common antihypertensive drugs.
  • To extract critical clinical features influencing the efficacy of Irbesartan, Metoprolol, Felodipine, Amlodipine, and Levamlodipine.

Main Methods:

  • Utilized spectrum analysis based on statistical methods and five machine learning algorithms.
  • Compared successful and unsuccessful treatment cases to identify significant clinical features.
  • Developed a visualized relative weight matrix by integrating statistical and machine learning results.

Main Results:

  • Identified distinct importance orders for 15 clinical features across the five antihypertensive agents.
  • The extracted clinical attributes for each drug were found to be clinically reasonable and meaningful.
  • Demonstrated that different hypertension drugs are associated with varying sets of critical patient features.

Conclusions:

  • The study provides a data-driven reference for personalized antihypertensive drug selection.
  • The identified clinical features can aid physicians in matching patients with the most effective hypertension medications.
  • This approach enhances the precision of hypertension treatment by considering individual patient profiles.